Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus® ACAT™ Model for Oral Absorption of PeptidesBusiness Wire • 01/05/21
Simulations Plus Sets Date for First Quarter Fiscal Year 2021 Earnings Release and Conference CallBusiness Wire • 01/04/21
Simulations Plus Publishes its Inaugural Environmental, Social and Governance (ESG) ReportBusiness Wire • 12/16/20
Simulations Plus Names Industry Veteran Will Frederick as Chief Financial OfficerBusiness Wire • 12/01/20
Simulations Plus' (SLP) CEO Shawn O'Connor on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/17/20
Simulations Plus (SLP) Q4 Earnings and Revenues Surpass EstimatesZacks Investment Research • 11/16/20
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2020 Earnings Release and Conference CallBusiness Wire • 11/09/20
Simulations Plus to Participate in the Credit Suisse Virtual Healthcare ConferenceBusiness Wire • 11/05/20
Simulations Plus Extends Partnership with Large Pharmaceutical Company to Further Expand High-Throughput PBPK Capabilities in ADMET Predictor®Business Wire • 09/29/20
Simulations Plus Partners with Large Pharmaceutical Company to Validate AI-Driven Drug Design Capabilities in ADMET Predictor®Business Wire • 09/22/20
Simulations Plus Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesBusiness Wire • 08/10/20
Simulations Plus Announces Pricing of $100 Million Underwritten Offering of Common StockBusiness Wire • 08/06/20